The drug is intended to treat pediatric patients 21 years and younger with acute lymphoblastic leukemia who’ve previously received at least two other treatments.
Clofarabine is the first generic version of Genzyme’s Clolar injection, which had sales of $67 million in 2016, according to IMS data.
More articles on supply chain:
Viewpoint: Why healthcare needs more ‘me too’ drugs
FDA safety warning: Diabetes drug causes higher risk of foot, leg amputations
FDA pauses Concert Pharma’s hair loss study: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
